Benjamin Edwards Inc’s Twist Bioscience TWST Stock Holding History

Benjamin Edwards Inc’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.24M	Sell	21,822 -4,956	-19%	-$322K	0.02%	543
2026 Q1	$1.27M	Sell	26,778 -2,854	-10%	-$128K	0.01%	674
2025 Q4	$940K	Buy	29,632 +1,309	+5%	+$40.8K	0.01%	735
2025 Q3	$797K	Buy	28,323 +4,410	+18%	+$134K	0.01%	772
2025 Q2	$880K	Buy	23,913 +2,343	+11%	+$81K	0.01%	671
2025 Q1	$847K	Buy	21,570 +3,864	+22%	+$174K	0.01%	627
2024 Q4	$823K	Buy	17,706 +5,033	+40%	+$227K	0.01%	675
2024 Q3	$572K	Buy	12,673 +12,549	+10,120%	+$597K	0.01%	756
2024 Q2	$6K	Sell	124 -72	-37%	-$2.94K	﹤0.01%	640
2024 Q1	$7K	Buy	196 +52	+36%	+$1.88K	﹤0.01%	661
2023 Q4	$5K	Sell	144 -108	-43%	-$2.5K	﹤0.01%	610
2023 Q3	$5K	Hold	252	–	–	﹤0.01%	601
2023 Q2	$5K	Buy	252 +58	+30%	+$869	﹤0.01%	613
2023 Q1	$3K	Buy	194 +152	+362%	+$3.36K	﹤0.01%	652
2022 Q4	$1K	Buy	+42	New	+$1.22K	﹤0.01%	710

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Benjamin Edwards Inc's TWST Position: Q2 2026 in Review

Benjamin Edwards Inc reduced its Twist Bioscience (TWST) stake by 19% in Q2 2026, selling an estimated $322K and leaving 21,822 shares worth $2.24M. The position accounts for 0.02% of the portfolio, ranked #543.

Benjamin Edwards Inc first reported a position in TWST in Q4 2022 and has held it in 15 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Benjamin Edwards Inc held 21,822 shares of Twist Bioscience worth $2.24M as of Q2 2026.
Benjamin Edwards Inc sold 4,956 Twist Bioscience shares in Q2 2026, an estimated $322K.
Twist Bioscience made up 0.02% of Benjamin Edwards Inc's portfolio in Q2 2026, its #543 holding.
Benjamin Edwards Inc first reported a position in Twist Bioscience in Q4 2022 and has held it in 15 quarters since.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.